Clinical trial
Efficacy, Safety and Tolerability of Multiple Doses of Oral Cebranopadol in Subjects With Moderate to Severe Chronic Pain Due to Diabetic Peripheral Neuropathy.
NCT01939366 is registered in ClinicalTrials.gov with Tris Pharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy, Safety and Tolerability of Multiple Doses of Oral Cebranopadol in Subjects With Moderate to Severe Chronic Pain Due to Diabetic Peripheral Neuropathy.
- Lead sponsor
- Tris Pharma, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 27, 2013
- Completion date
- January 28, 2015
- Enrollment
- 699 (actual)
- Sites
- 82
Conditions
As the registry lists them; a condition with its own page is linked.